Cholinesterase inhibitor treatment in patients with delirium

Lancet. 2011 Mar 12;377(9769):899; author reply 901. doi: 10.1016/S0140-6736(11)60341-3.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cholinesterase Inhibitors / adverse effects*
  • Cholinesterase Inhibitors / therapeutic use
  • Critical Illness*
  • Delirium / drug therapy*
  • Humans
  • Phenylcarbamates / adverse effects*
  • Phenylcarbamates / therapeutic use
  • Rivastigmine

Substances

  • Cholinesterase Inhibitors
  • Phenylcarbamates
  • Rivastigmine